{"id":"https://openalex.org/W2162821626","doi":"https://doi.org/10.1158/0008-5472.can-13-0890","title":"An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors","display_name":"An Intact Immune System Is Required for the Anticancer Activities of Histone Deacetylase Inhibitors","alternate_titles":[],"publication_year":2013,"publication_date":"2013-12-15","ids":{"openalex":"https://openalex.org/W2162821626","doi":"https://doi.org/10.1158/0008-5472.can-13-0890","mag":"2162821626","pmid":"https://pubmed.ncbi.nlm.nih.gov/24158093"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-13-0890","doi":"https://doi.org/10.1158/0008-5472.can-13-0890","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-0890","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2162821626"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109342619","display_name":"Alison C. West","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alison C. West","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047030847","display_name":"Stephen R. Mattarollo","orcid":"https://orcid.org/0000-0003-3659-6507","observed_orcids":["https://orcid.org/0000-0003-3659-6507"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen R. Mattarollo","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057674362","display_name":"Jake Shortt","orcid":"https://orcid.org/0000-0003-3185-6488","observed_orcids":["https://orcid.org/0000-0003-3185-6488"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jake Shortt","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060004543","display_name":"Leonie A. Cluse","orcid":"https://orcid.org/0000-0001-8613-0508","observed_orcids":["https://orcid.org/0000-0001-8613-0508"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leonie A. Cluse","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041951234","display_name":"Ailsa J. Christiansen","orcid":"https://orcid.org/0000-0002-8151-7444","observed_orcids":["https://orcid.org/0000-0002-8151-7444"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ailsa J. Christiansen","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061575707","display_name":"Mark John Smyth","orcid":"https://orcid.org/0000-0001-7098-7240","observed_orcids":["https://orcid.org/0000-0001-7098-7240"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark J. Smyth","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052829828","display_name":"Ricky W. Johnstone","orcid":"https://orcid.org/0000-0001-7053-9237","observed_orcids":["https://orcid.org/0000-0001-7053-9237"]},"institutions":[{"id":"https://openalex.org/I1308309334","display_name":"Translational Research Institute","ror":"https://ror.org/00v807439","country_code":"AU","type":"facility","lineage":["https://openalex.org/I1308309334"]},{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ricky W. Johnstone","raw_affiliation_strings":["Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081Cancer Therapeutics Program, and 2Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne; 3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria; 4The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba; 5Queensland Institute of Medical Research; and 6School of Medicine, University of Queensland, Herston, Queensland, Australia","institution_ids":["https://openalex.org/I1308309334","https://openalex.org/I165143802","https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.2267,"has_fulltext":false,"cited_by_count":146,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96157283,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"73","issue":"24","first_page":"7265","last_page":"7276"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":1.0},{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.996999979019165},{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.996999979019165},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7599999904632568},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7450000047683716},{"id":"https://openalex.org/keywords/ifn-gamma-receptor","display_name":"IFN-gamma receptor","score":0.8190000057220459},{"id":"https://openalex.org/keywords/immunogenic-tumor-cell-death","display_name":"immunogenic tumor cell death","score":0.6830000281333923},{"id":"https://openalex.org/keywords/alpha-galactosylceramide","display_name":"alpha-galactosylceramide","score":0.8500000238418579},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.8230000138282776},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7289999723434448},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.6990000009536743},{"id":"https://openalex.org/keywords/colon-adenocarcinoma","display_name":"colon adenocarcinoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7409999966621399},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.6740000247955322},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.8408903479576111},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5993896126747131},{"id":"https://openalex.org/C4951695","wikidata":"https://www.wikidata.org/wiki/Q18046437","display_name":"HDAC11","level":5,"score":0.5329317450523376},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.5201623439788818},{"id":"https://openalex.org/C71723506","wikidata":"https://www.wikidata.org/wiki/Q18026859","display_name":"Histone deacetylase 2","level":5,"score":0.49313634634017944},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4573080837726593},{"id":"https://openalex.org/C27253355","wikidata":"https://www.wikidata.org/wiki/Q18034954","display_name":"Histone deacetylase 5","level":5,"score":0.4386088252067566},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.42661362886428833},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39080002903938293},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3427852988243103},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3314419388771057},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23658478260040283},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18757393956184387},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.10224542021751404}],"mesh":[{"descriptor_ui":"D000096743","descriptor_name":"Interferon gamma Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007107","descriptor_name":"Immune System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007107","descriptor_name":"Immune System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007945","descriptor_name":"Leukemia, Lymphoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007945","descriptor_name":"Leukemia, Lymphoid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D017471","descriptor_name":"Receptors, Interferon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056572","descriptor_name":"Histone Deacetylase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-13-0890","doi":"https://doi.org/10.1158/0008-5472.can-13-0890","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-13-0890","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:24158093","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24158093","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322467","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1547450219","https://openalex.org/W1642873092","https://openalex.org/W1967018540","https://openalex.org/W1968356004","https://openalex.org/W1971921270","https://openalex.org/W1974991710","https://openalex.org/W1976555683","https://openalex.org/W1980881639","https://openalex.org/W1988380701","https://openalex.org/W1992240453","https://openalex.org/W1999145080","https://openalex.org/W2005853815","https://openalex.org/W2005908911","https://openalex.org/W2014095832","https://openalex.org/W2016612145","https://openalex.org/W2018050275","https://openalex.org/W2023980114","https://openalex.org/W2024746633","https://openalex.org/W2026318599","https://openalex.org/W2032348735","https://openalex.org/W2042687451","https://openalex.org/W2043322963","https://openalex.org/W2046238383","https://openalex.org/W2046729291","https://openalex.org/W2047509412","https://openalex.org/W2063511353","https://openalex.org/W2069019880","https://openalex.org/W2071951670","https://openalex.org/W2088587086","https://openalex.org/W2089189552","https://openalex.org/W2099115964","https://openalex.org/W2107894271","https://openalex.org/W2110957729","https://openalex.org/W2113195478","https://openalex.org/W2113520107","https://openalex.org/W2116556475","https://openalex.org/W2134403422","https://openalex.org/W2135834106","https://openalex.org/W2139607151","https://openalex.org/W2141570986","https://openalex.org/W2141615498","https://openalex.org/W2147820108","https://openalex.org/W2148448562","https://openalex.org/W2158545805","https://openalex.org/W2159959495","https://openalex.org/W2167415368","https://openalex.org/W2168523780","https://openalex.org/W2171365282","https://openalex.org/W2187258696","https://openalex.org/W2201914915","https://openalex.org/W2331551782","https://openalex.org/W2500312008"],"related_works":["https://openalex.org/W2011664887","https://openalex.org/W4323349721","https://openalex.org/W2104804115","https://openalex.org/W2095160131","https://openalex.org/W1974991710","https://openalex.org/W2042647692","https://openalex.org/W2295131371","https://openalex.org/W2074487427","https://openalex.org/W3025275008","https://openalex.org/W2001465534"],"abstract_inverted_index":{"Cell-intrinsic":[0],"effects":[1,31,93,156],"such":[2],"as":[3,15,212],"induction":[4],"of":[5,9,56,64,75,94,108,140,157,170,179,214],"apoptosis":[6],"and/or":[7],"inhibition":[8],"cell":[10,146],"proliferation":[11],"have":[12],"been":[13],"proposed":[14],"the":[16,54,57,62,90,95,132,138,154,168,215,241],"major":[17],"antitumor":[18,217],"responses":[19],"to":[20,35,52,119,166],"histone":[21],"deacetylase":[22],"inhibitors":[23],"(HDACi).":[24],"These":[25],"compounds":[26],"can":[27,41],"also":[28,42],"mediate":[29],"immune-modulatory":[30],"that":[32,176,231],"may":[33],"contribute":[34],"their":[36],"anticancer":[37,92,155],"effects.":[38],"However,":[39],"HDACi":[40,65,96,224],"induce":[43],"anti-inflammatory,":[44],"and":[45,78,98,104,144,159,161,230],"potentially":[46],"immunosuppressive,":[47],"outcomes.":[48],"We":[49,81],"therefore":[50],"sought":[51],"clarify":[53],"role":[55],"immune":[58,85,218],"system":[59,86],"in":[60,66,164,240],"mediating":[61],"efficacy":[63],"a":[67,101,177],"physiologic":[68],"setting,":[69],"using":[70],"preclinical,":[71],"syngeneic":[72],"murine":[73],"models":[74,107],"hematologic":[76],"malignancies":[77],"solid":[79],"tumors.":[80],"showed":[82],"an":[83,184],"intact":[84],"was":[87,187],"required":[88],"for":[89,153],"robust":[91],"vorinostat":[97,160,180,195,216],"panobinostat":[99],"against":[100,191],"colon":[102],"adenocarcinoma":[103],"two":[105],"aggressive":[106],"leukemia/lymphoma.":[109],"Importantly,":[110],"although":[111],"HDACi-treated":[112,126],"immunocompromised":[113],"mice":[114],"bearing":[115],"established":[116,192],"lymphoma":[117,193],"succumbed":[118],"disease":[120],"significantly":[121,188],"earlier":[122],"than":[123,194],"tumor":[124,145,171],"bearing,":[125],"wild-type":[127],"(WT)":[128],"mice,":[129],"treatment":[130,196,229],"with":[131,181,235],"conventional":[133],"chemotherapeutic":[134],"etoposide":[135],"equivalently":[136],"enhanced":[137],"survival":[139],"both":[141],"strains.":[142],"IFN-\u03b3":[143,162],"signaling":[147],"through":[148],"IFN-\u03b3R":[149],"were":[150,210],"particularly":[151],"important":[152],"HDACi,":[158],"acted":[163],"concert":[165],"enhance":[167],"immunogenicity":[169],"cells.":[172],"Furthermore,":[173],"we":[174],"show":[175],"combination":[178],"\u03b1-galactosylceramide":[182],"(\u03b1-GalCer),":[183],"IFN-\u03b3-inducing":[185],"agent,":[186],"more":[189],"potent":[190],"alone.":[197],"Intriguingly,":[198],"B":[199],"cells,":[200,209],"but":[201],"not":[202],"natural":[203],"killer":[204],"cells":[205],"or":[206],"CD8(+)":[207],"T":[208],"implicated":[211],"effectors":[213],"response.":[219],"Together,":[220],"our":[221],"data":[222],"suggest":[223],"are":[225],"immunostimulatory":[226],"during":[227],"cancer":[228],"combinatorial":[232],"therapeutic":[233],"regimes":[234],"immunotherapies":[236],"should":[237],"be":[238],"considered":[239],"clinic.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2162821626","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":23},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
